Publication | Closed Access

Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis

InflammationAutoimmune DiseaseImmune RegulationImmunologyExperimental Autoimmune EncephalomyelitisAutoimmunityAutoantibodiesMouse Relapse-remission ModelImmune FunctionNeurologyMultiple SclerosisImmunologic DiseaseMedicineNeuroinflammation